The convalescent sera option for containing COVID-19.J Clin Invest. 2020 Apr 01; 130(4):1545-1548.JCI
Links
MeSH
Pub Type(s)
Historical Article
Journal Article
Research Support, N.I.H., Extramural
Language
eng
PubMed ID
32167489
Clinical Trial Links
Effectiveness of Convalescent Plasma Therapy in 8 Non-Intubated COVID-19 Patients in Indonesia: A Case Series
Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19
Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection
Citation
Casadevall, Arturo, and Liise-Anne Pirofski. "The Convalescent Sera Option for Containing COVID-19." The Journal of Clinical Investigation, vol. 130, no. 4, 2020, pp. 1545-1548.
Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. 2020;130(4):1545-1548.
Casadevall, A., & Pirofski, L. A. (2020). The convalescent sera option for containing COVID-19. The Journal of Clinical Investigation, 130(4), 1545-1548. https://doi.org/10.1172/JCI138003
Casadevall A, Pirofski LA. The Convalescent Sera Option for Containing COVID-19. J Clin Invest. 2020 Apr 1;130(4):1545-1548. PubMed PMID: 32167489.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - The convalescent sera option for containing COVID-19.
AU - Casadevall,Arturo,
AU - Pirofski,Liise-Anne,
PY - 2020/3/14/pubmed
PY - 2020/4/9/medline
PY - 2020/3/14/entrez
KW - COVID-19
SP - 1545
EP - 1548
JF - The Journal of clinical investigation
JO - J Clin Invest
VL - 130
IS - 4
SN - 1558-8238
UR - https://www.unboundmedicine.com/medline/citation/32167489/full_citation
DB - PRIME
DP - Unbound Medicine
ER -